ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020
Nocturnal oxygen therapy as an option for early COVID-19.
Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 17 citations in OpenAlex.
- Effect of hydrogen/oxygen therapy for ordinary COVID-19 patients: a propensity-score matched case-control study.BMC infectious diseases · 2023Article
- Recent trends in the nanozeolites-based oxygen concentrators and their application in respiratory disorders.Frontiers in medicine · 2023Review
- SARS-COV-2 - the pandemic of the XXI century, clinical manifestations - neurological implications.Journal of medicine and life · 2022Review
- The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.International journal of environmental research and public health · 2021Review
- Efficiency of antiviral treatment in COVID-19.Experimental and therapeutic medicine · 2021Article
- In Reply - Does Hypoxia Itself Beget Worsening Hypoxemia in COVID-19?Mayo Clinic proceedings · 2021Article
- Could targeting immunometabolism be a way to control the burden of COVID-19 infection?Microbes and infectionReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.